Company Filings — 4 June 2026

968 regulatory filings were published by NSE- and BSE-listed companies on 4 June 2026 — showing page 1 of 10.

  1. Update on Unitop Chemicals Arbitration

    Rossari Biotech Ltd · ROSSARI · BSE ·

    • The company has been served a petition by the former shareholders of its material subsidiary, Unitop Chemicals Pvt. Ltd. • This petition challenges the final arbitration award that was passed in the company's favor on January 21, 2026. • The dispute is related to the Share Purc…

  2. Legal Challenge Filed in Unitop Chemicals Arbitration

    Rossari Biotech Limited · ROSSARI · NSE ·

    The company was served a petition on June 04, 2026, from the former shareholders of its subsidiary, Unitop Chemicals Private Limited. The petition challenges the final Arbitration Award that was rendered on January 21, 2026. This legal challenge has been filed under Section 34 of…

  3. FY26 Results: 2-Wheeler Growth Shines Amidst Mixed Performance

    Delta Autocorp Limited · DELTIC · NSE ·

    <b>FY26 Financials:</b> Reports total revenue from operations of ₹7,958.16 Lakhs (-4.3% YoY) and Profit After Tax (PAT) of ₹691.03 Lakhs (-17.7% YoY). <b>Top Performing Segment:</b> The Electric 2-Wheeler (2W) segment was the standout, with revenue surging 41.6% to become the lar…

  4. Receives Tax Order for FY23, Plans to Appeal

    Mastek Limited · MASTEK · NSE ·

    Received a final assessment order from the Income Tax Department for the Financial Year 2022-2023. The order includes Transfer Pricing adjustments of ₹90.95 crore and other income additions of ₹32.62 crore, with penalty proceedings initiated. Management believes the order contain…

  5. FY25 Sustainability Report: Key Governance & ESG Insights

    Sanofi Consumer Healthcare India Ltd · SANOFICONR · BSE ·

    <b>Business Context:</b> Became an independent entity on June 1, 2024, following a demerger, which affects year-on-year data comparison. <b>Financial Snapshot:</b> Reported a turnover of ₹8,784 Million and a net worth of ₹3,840 Million for the financial year. <b>Governance:</b> T…

  6. Scheduled Investor Meeting

    Elgi Equipments Limited · ELGIEQUIP · NSE ·

    • The company has scheduled a one-to-one physical meeting with institutional investor, Wasatch Global Investors. • The meeting will take place on June 9, 2026, at 4:00 PM IST in Coimbatore. • Attendees from the investor side include Lead Portfolio Manager, Mr. Ajay Krishnan.

  7. Q4 FY26 Fund Utilization Report: ₹471 Cr Deployed, IT Raid Disclosed

    Balu Forge Industries Ltd · BALUFORGE · BSE ·

    • <b>Fund Utilization:</b> Out of ₹496.80 Cr raised via a preferential issue, ₹471.12 Cr has been utilized as of March 31, 2026, leaving an unutilized amount of ₹25.68 Cr. • <b>Project Progress:</b> The capex for new plant & machinery is ongoing with no delays. The objectives for…

  8. Lupin Secures US FDA Approval for Ranluspec™ Biosimilar

    Lupin Ltd · LYKALABS · BSE ·

    Lupin has received U.S. FDA approval for its Ranluspec™ (ranibizumab) injection. Ranluspec™ is an interchangeable biosimilar to Genentech's Lucentis®, used to treat various eye conditions like wet age-related macular degeneration. It is the only ranibizumab biosimilar in the U.S.…

  9. Disputes Income Tax Order with ₹123.58 Crore Addition

    Mastek Ltd · MASTEK · BSE ·

    Received a Final Assessment Order from the Income Tax Department for FY 2022-23 with a total proposed income addition of **₹1,23,58,26,194** (approx. ₹123.58 Crore). The additions are primarily due to transfer pricing (₹90.95 Cr) and domestic tax laws (₹32.62 Cr). The company pla…

  10. Independent Directors Recommend Open Offer, Note Price Disparity

    Novartis India Ltd · NOVARTIND · BSE ·

    The Committee of Independent Directors (IDC) has recommended the mandatory open offer made by a ChrysCapital-led consortium to public shareholders. The offer price is **₹860.64** per share to acquire up to 26% of the company's share capital. While the IDC deems the price "fair an…

  11. Strong FY25 Results: PAT Up 33%, Final Dividend of ₹75/Share

    Sanofi Consumer Healthcare India Ltd · SANOFICONR · BSE ·

    **Financial Highlights (FY25):** Revenue from Operations grew 21% YoY to ₹8,784 Million, while Profit After Tax (PAT) surged 33% to ₹2,401 Million. Basic EPS stood at ₹104.27. **Dividend Declared:** The Board has recommended a final dividend of ₹75 per equity share for the financ…

  12. Update on Utilization of Funds from Preferential Issues

    Balu Forge Industries Ltd · BALUFORGE · BSE ·

    • The company filed its mandatory compliance report for the quarter ended March 31, 2026, detailing the use of funds from recent preferential issues. • It has formally confirmed that there is **no deviation or variation** in the utilization of funds from the stated objectives in…

  13. AGM Notice: Final Dividend & New Auditor Appointment

    Sanofi Consumer Healthcare India Limited · SANOFICONR · NSE ·

    **3rd AGM**: The Annual General Meeting will be held on Friday, 26 June 2026, at 3:00 P.M. (IST) via video conference. **Final Dividend**: The Board has recommended a final dividend of **₹75 per equity share**. **Record Date**: 19 June 2026 **Payment Date**: 09 July 2026 **Audito…

  14. AGM Notice: Final Dividend of ₹75/Share & Key Resolutions Proposed

    Sanofi Consumer Healthcare India Limited · SANOFICONR · NSE ·

    The 3rd Annual General Meeting (AGM) will be held on Friday, 26th June 2026, via Video Conference. A final dividend of **Rs. 75 per equity share** for the financial year ended 31st December 2025 has been proposed for shareholder approval. A resolution will be proposed for the re-…

  15. Fund Utilization Update: On Track with No Deviations

    Balu Forge Industries Limited · BALUFORGE · NSE ·

    **Declaration:** The company confirms **"No deviation or variation"** in the use of proceeds for the quarter ended March 31, 2026. **Fund Raise Details:** A total of **₹17,280 Lakhs** was raised through preferential issues between February and March 2026. **Utilization Status:**…

  16. U.S. FDA Approves Lupin's Biosimilar Ranluspec™

    Lupin Limited · LUPIN · NSE ·

    Lupin has received U.S. FDA approval for Ranluspec™ (ranibizumab), an interchangeable biosimilar to Genentech's Lucentis®. The drug is indicated for treating serious eye conditions like neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema. Ranluspec…

  17. Trading Window Closure Announced

    Kirloskar Ferrous Industries Ltd · KIRLFER · BSE ·

    • The company has announced the closure of its trading window for Designated Persons and their immediate relatives. • The closure period is from June 5, 2026, to June 16, 2026 (both days inclusive). • This action is in compliance with SEBI (Prohibition of Insider Trading) Regulat…

  18. Company Explains 9-Month Delay in Reporting Director's Exit

    GTT Data Solutions Ltd · 530457 · BSE ·

    Mr. Samarjeetsinh Vikramsinh Ghatge has vacated his office as an Independent Director, effective August 14, 2025. The reason for the vacation was his absence from all board meetings for a period of 12 months, as per Section 167(1)(b) of the Companies Act, 2013. The company disclo…

  19. Approves FY26 Financials & Re-appoints Internal Auditor

    Ambo Agritec Ltd · 543678 · BSE ·

    The Board of Directors has approved the Audited Financial Results for the quarter and year ended March 31, 2026. The statutory auditor's report on the financials carried an unmodified opinion, indicating no significant issues were found. The Board has re-appointed Agarwal K Assos…

  20. Board Approves ₹6.84 Crore Fundraise via Preferential Share Issue

    Novelix Pharmaceuticals Ltd · 536565 · BSE ·

    The Board has approved a proposal to raise **₹6.84 crore** by issuing **12,00,000 equity shares** on a preferential basis. The issue price is set at **₹57 per share** (Face Value: ₹10, Premium: ₹47). The shares will be allotted to 18 individuals from the "Non-Promoter" category.…

  21. Analyst & Investor Meet Concluded

    The Federal Bank Limited · FEDERALBNK · NSE ·

    The bank has informed the stock exchanges about the conclusion of its Analyst / Institutional Investor Meet held on June 4, 2026. This filing serves as a regulatory notification confirming the interaction has occurred. No material information, presentations, or substantive detail…

  22. Bags New International Order Worth ₹2.59 Crore

    DMR Engineering Ltd · 543410 · BSE ·

    <b>Nature of Order:</b> To provide Owner's Engineer Services for the 1125MW Dorjilung Hydropower Project. <b>Awarding Entity:</b> Dorjilung Hydro Power Limited, Bhutan. <b>Contract Value:</b> ₹2,58,91,500 (approx. ₹2.59 Crore), exclusive of taxes. <b>Execution Period:</b> 9 month…

  23. Board Approves FY26 Financials & Re-appoints Internal Auditor

    Ambo Agritec Ltd · 543678 · BSE ·

    The Board of Directors has approved the Audited Financial Results for the year ended March 31, 2026. The company received an unmodified (clean) opinion on its financials from the Statutory Auditors, M/s. A. O. Mittal & Associates. Agarwal K Assosicates has been re-appointed as th…

  24. FY26 Sustainability Report: Green Initiatives & Safety Red Flags

    Dalmia Bharat Ltd · DALBHARAT · BSE ·

    **Filing:** Submitted the Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, with "reasonable assurance" provided by TUV India on core ESG data. **Strategy:** Outlined major expansion plans, including new grinding units in UP & Haryana and a new cement plant…

  25. Update on Analyst & Investor Meeting

    Federal Bank Ltd · FEDERALBNK · BSE ·

    Federal Bank's management participated in a group meeting with analysts and investors on June 04, 2026, as part of the Citi India Conference 2026 in Mumbai. Key participants included SBI Mutual Fund, General Atlantic, ICICI Prudential Mutual Fund, and White Oak Capital, among oth…

  26. Promoter Increases Stake in Company

    Stanley Lifestyles Limited · STANLEY · NSE ·

    Promoter Mr. Sunil Suresh acquired 1,01,000 equity shares through an open market purchase on June 3, 2026. The total value of the transaction was ₹1,46,88,935 (approx. ₹1.47 crore). This acquisition increased the promoter's shareholding from 28.35% to 28.47%. The disclosure was m…

  27. Confirms Timely NCD Interest Payment & Redemption

    Cholamandalam Investment and Finance Company Limited · CHOLAFIN · NSE ·

    The company has confirmed the timely payment of interest and full principal redemption for two series of its Non-Convertible Debentures (NCDs) that matured on June 4, 2026. **For ISIN INE121A07QW3:** Paid interest of ₹125.03 Lakhs and redeemed the full principal of ₹18,720.62 Lak…

  28. Kopran's Amalgamation Scheme Receives Overwhelming Approval

    Kopran Limited · KOPRAN · NSE ·

    Shareholders and creditors have approved the Scheme of Amalgamation of Kopran Laboratories Limited with Kopran Limited. The resolution was passed with an overwhelming majority in meetings held on June 03, 2026, convened by the National Company Law Tribunal (NCLT). **Voting Result…

  29. Successfully Redeems Non-Convertible Debt Securities

    Cholamandalam Investment and Finance Company Limited · CHOLAFIN · NSE ·

    The company has confirmed the timely payment of interest and the full redemption of two series of Non-Convertible Debt securities (NCDs) on their maturity date, June 4, 2026. The specific NCDs, with ISINs INE121A07QW3 and INE121A07QZ6, have been fully redeemed, and the outstandin…

  30. Confirms Timely Payment and Redemption of NCDs

    Cholamandalam Investment and Finance Company Limited · CHOLAFIN · NSE ·

    The company has confirmed the timely payment of interest and full redemption of two series of Non-Convertible Debentures (NCDs) on their maturity date, June 4, 2026. A total of ₹19,890.8 Lakhs was paid to debenture holders, covering both principal and final interest for the NCDs…

  31. ACME Solar Raises ₹2,800 Crore via Share Sale to Institutions

    ACME Solar Holdings Ltd · ACMESOLAR · BSE ·

    Successfully completed a Qualified Institutions Placement (QIP), raising approximately ₹28,000 million (₹2,800 crore). Allotted 10,01,78,890 new equity shares at an issue price of ₹279.50 per share. The company's paid-up equity share capital has increased by approximately 16.53%…

  32. FY26 Annual Report: Record EBITDA, Acquires JP Assets & ₹9 Dividend

    Dalmia Bharat Limited · DALBHARAT · NSE ·

    <ul> <li><b>Financial Highlights (YoY):</b> Revenue up 6% to ₹14,804 Cr, Operating EBITDA up 28% to ₹3,083 Cr, and PAT up 66% to ₹1,157 Cr.</li> <li><b>Dividend:</b> Recommended a final dividend of ₹5.00/share. Total dividend for FY26 stands at ₹9.00/share.</li> <li><b>Major Acqu…

  33. Promoter Group Shareholding Update

    Enbee Trade & Finance Ltd · 512441 · BSE ·

    A member of the Promoter Group, Meyhul Gaala, has acquired 5.93 crore shares, representing an 8.50% stake in the company. The acquisition was an "inter-se transfer," a transaction between members of the promoter group, dated June 03, 2026. Following the transaction, Meyhul Gaala'…

  34. Board Approves ₹460 Cr Fundraise & Increases Stake in Defence Subsidiary

    Sigma Advanced Systems Ltd · SIGMAADV · BSE ·

    • <b>Fundraise:</b> The board approved raising up to ₹460 Crores by issuing 1.32 crore equity shares at ₹347/share to non-promoters on a preferential basis. • <b>Subsidiary Stake Hike:</b> Approved the acquisition of an additional 25% stake in its defence subsidiary, AS Strategic…

  35. Shareholders & Creditors Approve Amalgamation Scheme

    Kopran Ltd · KOPRAN · BSE ·

    • <b>Scheme Approved:</b> The Scheme of Amalgamation to merge Kopran Laboratories Ltd (Transferor) with Kopran Ltd (Transferee) has been approved in NCLT-convened meetings held on June 03, 2026. • <b>Overwhelming Shareholder Support:</b> The resolution was passed with <b>99.9551%…

  36. Announces 13th AGM, Proposes ₹5 Final Dividend & Fund-Raising

    Dalmia Bharat Limited · DALBHARAT · NSE ·

    The 13th Annual General Meeting (AGM) will be held on Tuesday, June 30, 2026, at 11:30 A.M. (IST) via video conference. A final dividend of **₹ 5/- per equity share (250%)** for the financial year ended March 31, 2026, will be proposed for shareholder approval. The agenda include…

  37. Board Appoints Cost Auditor for FY 2026-27

    Anya Polytech & Fertilizers Limited · ANYA · NSE ·

    The Board of Directors has approved the appointment of M/s Yash Sardana & Associates as the Cost Auditor. The appointment is for the financial year 2026-27, covering the period from April 1, 2026, to March 31, 2027. The approval was granted on June 04, 2026, based on the recommen…

  38. Appointment of New Cost Auditors

    Anya Polytech & Fertilizers Limited · ANYA · NSE ·

    • The company has appointed M/s. Yash Sardana & Associates as its new Cost Auditors. • The appointment is effective from 04 June 2026. • The term of the appointment is for 12.

  39. Technical Issue with Latest Filing

    Dalmia Bharat Ltd · DALBHARAT · BSE ·

    • The document filed is an inaccessible PDF portfolio, acting as a technical placeholder. • Viewing the actual content requires specific software (Adobe Acrobat/Reader X or later). • Due to this, no material information regarding financials, operations, or strategy could be analy…

  40. Promoter Group Member Acquires 8.50% Stake in Inter-se Transfer

    Enbee Trade & Finance Ltd · 512441 · BSE ·

    Meyhul Gaala, a member of the Promoter Group, has acquired 5,93,00,100 equity shares of the company. The transaction was an inter-se transfer (an internal transfer of shares within the Promoter Group) valued at ₹5.93 crore. Post-acquisition, Mr. Gaala's shareholding has increased…

  41. Boosts Shareholding in Subsidiary HPL to 96.6%

    Hindware Home Innovation Limited · HINDWAREAP · NSE ·

    • Received an allotment of 1,50,00,000 equity shares in its subsidiary, Hintastica Private Limited (HPL), through a Rights Issue. • The company's total shareholding in HPL has now increased to 96.6% of the paid-up share capital. • This move solidifies control over the subsidiary…

  42. Promoter Group Member Acquires 5.69% Stake

    Enbee Trade & Finance Ltd · 512441 · BSE ·

    Bharathi Narendra Gala, a member of the Promoter Group, has acquired 3,97,06,810 equity shares. Post-acquisition, her stake in the company stands at 5.69%. Prior to this, she held no shares. The acquisition was made through an 'Inter-se Transfer' (a transfer within the promoter g…

  43. Red Flags Raised in IPO Fund Utilization Report

    Anya Polytech & Fertilizers Limited · ANYA · NSE ·

    <b>Material Deviation:</b> A monitoring agency report found the company materially deviated from its stated IPO objectives, reallocating funds from capital projects to working capital. <b>Governance Lapse:</b> The company failed to obtain the required shareholder approval for the…

  44. Announces 26th AGM & Final Dividend Dates

    Thyrocare Technologies Limited · THYROCARE · NSE ·

    The 26th Annual General Meeting (AGM) is scheduled for Tuesday, June 30, 2026, at 11:00 A.M. (IST). A Final Dividend for FY 2025-26 has been proposed. The record date is set for Tuesday, June 23, 2026. The e-voting period will run from Friday, June 26, 2026, to Monday, June 29, 2…

  45. Technical Notice on Filing Format

    Dalmia Bharat Ltd · DALBHARAT · BSE ·

    The document is a technical placeholder image, not a substantive corporate filing. No material financial, operational, or strategic information has been disclosed. To view the content, the PDF portfolio must be opened using Adobe Acrobat X, Adobe Reader X, or a later version.

  46. Significant Change in Promoter Shareholding

    Enbee Trade & Finance Ltd · 512441 · BSE ·

    • Promoter Amarr Narendra Galla has sold 9.90 crore shares, representing a 14.20% stake in the company. • His individual shareholding has been reduced from 24.45% to 10.25%. • The transaction was an "Inter-se Transfer," meaning the shares were transferred within the promoter grou…

  47. Boosts Stake in Subsidiary to 96.6%

    Hindware Home Innovation Ltd · HINDWAREAP · BSE ·

    • Hindware Home Innovation Ltd has been allotted 1,50,00,000 equity shares in its subsidiary, Hintastica Private Limited (HPL). • The allotment was made pursuant to the company's subscription to a Rights Issue of HPL. • Following the transaction, the company's shareholding in HPL…

  48. Promoter Amarr Galla's Stake Drops to 10.25% After Share Sale

    Enbee Trade & Finance Ltd · 512441 · BSE ·

    Promoter Mr. Amarr Narendra Galla sold 9,90,06,910 equity shares via an inter-se transfer on June 03, 2026. An inter-se transfer implies the shares were moved within the promoter group. As a result, his individual shareholding in the company has reduced from 24.45% to 10.25%. The…

  49. Thyrocare's FY26 Sustainability Report: Key ESG & Operational Highlights

    Thyrocare Technologies Limited · THYROCARE · NSE ·

    📈 **Financial Performance:** The company reported a turnover of ₹774.27 Crore for FY26, with its primary business of Diagnostics/Pathological Labs contributing 98.66%. 👥 **Employee Turnover:** Showed significant improvement, with the permanent employee turnover rate decreasing…

  50. Upcoming Analyst/Investor Meeting

    Multi Commodity Exchange of India Ltd · MCX · BSE ·

    The company has scheduled a virtual one-on-one meeting with Tusk Investments. The meeting is set for Tuesday, June 9, 2026. This is a supplementary disclosure as per SEBI regulations and does not contain new financial results or material information. The company has noted that th…

  51. AGM Notice: Final Dividend, CEO Re-appointment & New Auditor Proposed

    Thyrocare Technologies Limited · THYROCARE · NSE ·

    The 26th Annual General Meeting (AGM) is scheduled for June 30, 2026, to be held physically in Navi Mumbai. A final dividend of **₹7.00 per equity share** has been proposed for the financial year ended March 31, 2026. Shareholder approval is sought for the re-appointment of **Mr.…

  52. Auditor Flags Major Issues in IPO Fund Utilization

    Anya Polytech & Fertilizers Limited · ANYA · NSE ·

    **Fund Diversion:** Funds for capital expenditure were diverted to working capital without shareholder approval, a major governance red flag noted by the auditor. **Project Delays:** Key projects scheduled for completion in FY25 are significantly delayed and remain "Ongoing." **N…

  53. Upcoming Investor Meeting with Wasatch Global Investors

    Elgi Equipments Ltd · ELGIEQUIP · BSE ·

    • The company will hold a one-on-one physical meeting with M/s Wasatch Global Investors on June 09, 2026. • Elgi has stated that no unpublished price-sensitive information will be disclosed during the meeting. • The schedule is subject to change.

  54. NTPC Signs Agreement to Expand Meja Power Project

    NTPC Ltd · NTPC · BSE ·

    Signed a Supplementary Joint Venture Agreement (SJVA)-III with Uttar Pradesh Rajya Vidyut Utpadan Nigam Limited (UPRVUNL) on June 4, 2026. The agreement is for their 50:50 Joint Venture, Meja Urja Nigam Private Limited (MUNPL). It formalizes the capacity enhancement of the Meja S…

  55. Strategic Investment in Alternative Fund

    Glance Finance Ltd · 531199 · BSE ·

    Commits to invest up to ₹5 Crore as a Sponsor in an Alternative Investment Fund (AIF). The target fund is 'Artha Fund VI AQF I', a Category II AIF managed by Artha India Holdings Pvt. Ltd. This move is part of the company's strategy as an NBFC to invest in private equity and simi…

  56. Senior Management Reshuffle Announced

    Bank of Baroda · BANKBARODA · BSE ·

    Mr. Singh Sanjay Kumar has been appointed as Head - Financial Inclusion & CSR. Mr. Shukla Saurabh Ravishankar's designation has been changed to CGM, Officer On Special Duty, IT Projects. Mr. Nema Rakesh's designation has been changed to CGM, IT Operations, Infrastructure, & Proje…

  57. Clarifies Delay in FY26 Financial Results

    Jaiprakash Associates Limited · JPASSOCIAT · NSE ·

    The company is responding to an NSE query regarding the delay in submitting its financial results for the year ended March 31, 2026. The delay is justified under SEBI regulations, which allow a 120-day timeline for companies with an approved resolution plan under the Insolvency &…

  58. FY'26: Record Profits & EV Arm Turns Profitable

    Ashok Leyland Limited · ASHOKLEY · NSE ·

    Reports best-ever annual performance in FY'26, achieving all-time highs in revenue (₹44,007 Cr, +13.6%), profit, and CV volume. EV subsidiary, Switch Mobility, achieved its first-ever net profit of over ₹100 Crores, driven by a 238% growth in e-bus deliveries. LCV business record…

  59. Bilcare Lets Warrants in Caprihans India Expire, Forfeits ₹1.57 Crore

    Bilcare Ltd · BI · BSE ·

    • The Board of Directors has decided not to exercise 3,15,000 warrants held in Caprihans India Limited. • The decision was based on the company's liquidity position and capital allocation priorities. • As a result, the upfront subscription amount of ₹1,57,50,000 paid for the warr…

  60. Posts Record FY'26 Results, Declares Dividend

    Ashok Leyland Ltd · ASIANPAINT · BSE ·

    Reported its best-ever annual performance in FY'26, achieving all-time highs in revenue, profit, and Commercial Vehicle (CV) volume. FY'26 consolidated revenue grew 13.6% YoY to ₹44,007 Crores, with an EBITDA margin of 13.0% and a net cash position of ₹5,899 Crores. The Board rec…

  61. Record Date for Final Dividend (FY26) Announced

    Thyrocare Technologies Ltd · THYROCARE · BSE ·

    The company has fixed **Tuesday, June 23, 2026**, as the Record Date for its final dividend for the financial year 2025-26. **Dividend Amount:** ₹7.00 per share. **Payment Date:** The dividend will be paid on or before July 29, 2026. The dividend is subject to shareholder approva…

  62. Notice for 87th AGM: Dividend & Director Re-appointment Proposed

    Tata Chemicals Limited · TATACHEM · NSE ·

    • The 87th Annual General Meeting (AGM) will be held on June 26, 2026, via video conference. • A dividend of <b>₹11 per share</b> has been proposed for the financial year ended March 31, 2026. • The agenda includes the re-appointment of <b>Mr. S. Padmanabhan</b> as a Non-Executiv…

  63. FY26 Sustainability Report: Key ESG Metrics & Initiatives

    Thyrocare Technologies Ltd · THYROCARE · BSE ·

    **Financial Snapshot (FY26):** The company reported a standalone turnover of ₹774.27 Crore. Diagnostics and pathological lab activities constitute 98.66% of turnover. **ESG Initiatives:** Advanced sustainability efforts by installing solar panels and operating Sewage/Effluent Tre…

  64. FY26 Sustainability Report: Decarbonization Push Amid Legal & Safety Headwinds

    Tata Chemicals Ltd · TATACHEM · BSE ·

    <b>Legal Setback:</b> Received an adverse Gujarat High Court ruling on a land dispute at its Mithapur plant; faces potential financial liability for environmental compensation, with the amount yet to be determined. <b>Strategic Acquisition:</b> Completed the acquisition of Novaba…

  65. FY26 BRSR Highlights: ESG Progress, New Acquisition, and Key Legal Update

    Tata Chemicals Limited · TATACHEM · NSE ·

    **Report Filed**: Submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, reporting a consolidated turnover of ₹ 14,584 Crore. **Acquisition Completed**: Acquired 100% of **Novabay Pte. Limited** on March 19, 2026, making it a wholly-owned subsidiar…

  66. FY27 Guidance: Targeting 30% Growth & PAT Breakeven

    Fratelli Vineyards Ltd · 541741 · BSE ·

    <b>FY27 Outlook:</b> Management is targeting <b>~30% revenue growth</b> to approximately ₹240 crores and expects to achieve <b>net profit (PAT) breakeven</b>. <b>Q4 FY26 Performance:</b> Revenue grew <b>13% YoY</b> to ₹36 crores, with a significantly reduced EBITDA loss, driven b…

  67. Approves DLG up to ₹180 Cr; Key Independent Director to Step Down

    One 97 Communications Limited · PAYTM · NSE ·

    The company has approved providing a Default Loss Guarantee (DLG) of up to **₹90 Crores each** to its lending partners, Muthoot Fincorp Limited and Kisetsu Saison Finance (India) Private Limited. Mr. Ashit Ranjit Lilani, a Non-Executive Independent Director, will cease his direct…

  68. IHCL's FY26 Sustainability Report: Progress on 'Paathya' Framework & Net Zero Goals

    The Indian Hotels Company Limited · INDHOTEL · NSE ·

    This is the Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, detailing the company's ESG performance under its "Paathya" framework. <b>Key Goals:</b> The company has set a target to achieve Net Zero emissions by 2045 and reduce absolute Scope 1 & 2 GHG emi…

  69. Reports Stellar FY26: PAT Soars 79%, Declares 2:1 Bonus & ₹9.33/Share Dividend

    Thyrocare Technologies Limited · THYROCARE · NSE ·

    **Strong Financials (FY26):** Revenue grew 20.6% to ₹829 Cr, while Profit After Tax (PAT) surged 79% to ₹163 Cr. Basic EPS stood at ₹10.27. **Major Shareholder Rewards:** The company issued Bonus Shares in a 2:1 ratio and recommended a total dividend of ₹9.33 per share (post-bonu…

  70. Independent Director to Step Down from Board

    One 97 Communications Limited · PAYTM · NSE ·

    Mr. Ashit Ranjit Lilani, a Non-Executive Independent Director, will cease his position on the Board of Directors effective July 04, 2026. The reason for his departure is the withdrawal of his consent for re-appointment, citing "other professional commitments". Upon his cessation,…

  71. FY26 Report: 21% Revenue Growth, 2:1 Bonus Issue & Dividend Declared

    Thyrocare Technologies Ltd · THYROCARE · BSE ·

    • <b>Financials:</b> Consolidated Revenue grew 20.6% YoY to ₹829.04 Cr, driven by a 22.6% growth in the Pathology segment. Consolidated Profit Before Tax stood at ₹212.88 Cr. • <b>Bonus Issue:</b> The company completed a 2:1 bonus issue, allotting two new shares for every one exi…

  72. Notice of 87th AGM, Proposes ₹11 Dividend

    Tata Chemicals Ltd · TATACHEM · BSE ·

    **AGM Details:** The 87th Annual General Meeting will be held virtually on Friday, June 26, 2026, at 3:00 p.m. IST. **Dividend Proposed:** The Board has recommended a dividend of **₹11 per ordinary share** (110%) for FY 2025-26. **Record Date:** The record date for dividend eligi…

  73. IHCL's FY26 Sustainability Report Highlights Strong ESG Progress & Future Goals

    Indian Hotels Company Ltd · INDHOTEL · BSE ·

    The company filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, detailing its performance under the 'Paathya' ESG+ framework. <b>Environmental Performance</b>: Achieved 54% of total electricity consumption from renewable sources, sur…

  74. Bags Major Sub-Contract for Jaipur Metro Phase-II

    IL&FS Engineering and Construction Company Ltd · IL&FSENGG · BSE ·

    The company has been awarded a sub-contract for the Jaipur Metro Phase-II MRTS project. The scope includes the design and construction of an Elevated Viaduct and ten Elevated Stations. The company's share of the contract value is ₹414.05 Crore (inclusive of taxes). This represent…

  75. FY26 Annual Report: Profit Crosses ₹2,000 Cr, Revenue Jumps 16%

    Indian Hotels Company Ltd · INDHOTEL · BSE ·

    <b>Financial Performance (FY26):</b> Total Income grew 16% to ₹9,971 Cr, and Profit After Tax (PAT) rose 9% to ₹2,084 Cr. EBITDA margin stood strong at 34.9%. <b>Strategic Acquisitions:</b> Acquired controlling stakes in ANK Hotels, Pride Hospitality, and Sparsh Infratech (Atmant…

  76. FY26 Annual Report: 21% Revenue Growth, Bonus Issue & ₹7 Final Dividend

    Thyrocare Technologies Ltd · THYROCARE · BSE ·

    <b>Financial Performance:</b> Consolidated revenue grew 20.6% YoY to ₹829 Cr for FY26, with Profit Before Tax at ₹212.88 Cr. The Pathology segment was the key driver, growing 22.6%. <b>Final Dividend:</b> The board has recommended a final dividend of ₹7.00 per equity share. The r…

  77. FY26 Annual Report: Dividend Held at ₹11/Share Despite Impairment-Driven Loss

    Tata Chemicals Ltd · TATACHEM · BSE ·

    **Financials:** The company reported a Consolidated Loss Before Tax of ₹(1,459) Cr on revenue of ₹14,584 Cr. The loss was driven by a one-time exceptional charge of ₹1,956 Cr, primarily a non-cash goodwill impairment in its US operations. **Dividend:** The Board has recommended a…

  78. Announces Closure of Hyderabad Manufacturing Unit

    United Spirits Ltd · UNITDSPR · BSE ·

    • The company has proposed the closure of its manufacturing unit located in Hyderabad. • This move is part of its ongoing "Supply Chain Agility Program". • The estimated date for the closure is 31st August 2026. • The unit contributed ~2% of total revenue (approx. ₹599 crore) in…

  79. Proposes Closure of Hyderabad Manufacturing Unit

    United Spirits Limited · UNITDSPR · NSE ·

    Proposed closure of its manufacturing unit in Hyderabad, with operations expected to cease by 31 August 2026. The move is part of the company's strategic "Supply Chain Agility Program" aimed at improving long-term efficiency. In FY 2025-26, the unit contributed 2% to total revenu…

  80. Paytm to Offer Loan Guarantees; Independent Director to Step Down

    One 97 Communications Limited · PAYTM · NSE ·

    • The company will provide a Default Loss Guarantee (DLG) of up to ₹90 Crores each to lending partners Muthoot Fincorp and Kisetsu Saison Finance to strengthen its loan distribution business. • Mr. Ashit Ranjit Lilani, a Non-Executive Independent Director, has withdrawn his conse…

  81. QIP Fundraiser Successfully Closed

    ACME Solar Holdings Ltd · ACMESOLAR · BSE ·

    <ul> <li>The Fund Raising Committee has approved the closure of the Qualified Institutions Placement (QIP).</li> </ul>

  82. QIP Closure: Raises ₹2,800 Crores in New Funding

    Acme Solar Holdings Limited · ACMESOLAR · NSE ·

    Successfully closed its Qualified Institutions Placement (QIP) on June 04, 2026. Raised approximately **₹2,800 Crores** by allotting **10,01,78,890** new equity shares. The issue price was finalized at **₹279.50** per share. This price represents a 4.97% discount to the calculate…

  83. Successfully Raises ₹780.24 Crore via Share Allotment

    Ola Electric Mobility Limited · OLAELEC · NSE ·

    <b>Fundraise Complete:</b> Allotted 217.58 million equity shares through a Qualified Institutions Placement (QIP), raising approximately <b>₹780.24 Crore</b>. <b>Issue Price:</b> Shares were issued at <b>₹35.86 per share</b>, which represents a 4.98% discount to the floor price.…

  84. Court Lifts Restriction on Company Assets

    CARE Ratings Limited · CARERATING · NSE ·

    The Madras High Court has vacated a previous order dated February 1, 2023, that had restrained the company from the "alienation of assets." This injunction was lifted because the company has now complied with the requirements of the original court order. The removal of this restr…

  85. Analyst & Investor Call Transcript Now Available

    Oil & Natural Gas Corporation Limited · ONGC · NSE ·

    The company has published the transcript of its recent conference call with analysts and investors, held following communications on May 22 and May 27, 2026. The transcript can be accessed directly on the company's website at: `https://ongcindia.com/web/eng/transcription` This re…

  86. Analyst Call Transcript Released

    Oil and Natural Gas Corporation Ltd · ONGC · BSE ·

    • The company has notified the stock exchanges about the availability of the transcript for its recent Analyst/Investor conference call. • This filing is a compliance requirement under Regulation 30 of SEBI (LODR) Regulations, 2015. • The full transcript has been uploaded to the…

  87. Enser Unveils Ambitious Growth Plan: ₹500 Cr Revenue Target & AI Transformation

    Enser Communications Limited · ENSER · NSE ·

    **FY26 Performance**: Revenue from Operations grew 19.6% YoY to ₹101.16 Cr, with Profit After Tax (PAT) at ₹10.01 Cr. **Future Roadmap**: Set an ambitious revenue target of ₹500 Cr by FY2030, driven by a strategic shift to an "AI-Augmented Scalable Model". **Margin Expansion**: A…

  88. 125th AGM Notice: 325% Dividend & CEO Pay Revision Proposed

    The Indian Hotels Company Limited · INDHOTEL · NSE ·

    The 125th Annual General Meeting (AGM) will be held virtually on **Tuesday, June 30, 2026**, at 10:30 a.m. (IST). A final dividend of **₹3.25 per share** (325%) for FY 2025-26 has been proposed. The record date is **June 23, 2026**. Shareholder approval is sought to revise the MD…

  89. FY26 Results: Revenue Skyrockets 573%, but Net Profit Plummets 91.5%

    Sattva Sukun Lifecare Ltd · 539519 · BSE ·

    <b>FY26 Performance:</b> Total Income from Operations surged by 572.9% to ₹3,813.41 Lakhs. However, Net Profit (PAT) declined by 91.5% to ₹21.17 Lakhs. <b>Q4 FY26 Loss:</b> The company posted a net loss of ₹(70.99) Lakhs for the quarter, a sharp reversal from a profit of ₹84.22 L…

  90. Notice of 125th Annual General Meeting (AGM)

    Indian Hotels Company Ltd · INDHOTEL · BSE ·

    The company has issued a formal notice for its 125th Annual General Meeting (AGM). The meeting is scheduled for **Tuesday, June 30, 2026, at 10:30 a.m. (IST)**. This notice, which details the meeting's agenda, is a supplement to the Integrated Annual Report. The filing is made un…

  91. FY26 Results: Underlying Profit Grows Despite One-Time Charge

    NIS Management Ltd · 544495 · BSE ·

    <b>FY26 Performance:</b> Total Income grew 7.74% YoY to ₹436.70 Cr, while Q4 Income saw a stronger 13.96% YoY growth. <b>Profitability Impact:</b> Reported a Net Loss of ₹1.85 Cr for FY26, driven by a one-time, non-cash exceptional charge of ₹27.82 Cr related to new labour laws.…

  92. Upcoming Analyst & Investor Meet

    Metropolis Healthcare Ltd · METROPOLIS · BSE ·

    The company has scheduled a group meeting with Macquarie Healthcare Tour on June 08, 2026, starting at 03:30 p.m. (IST). It has been affirmed that no Unpublished Price Sensitive Information (UPSI) will be shared, and discussions will be limited to publicly available information.…

  93. FY26 Results: Revenue Skyrockets 512%, But Profits Collapse 91%

    Sattva Sukun Lifecare Ltd · 539519 · BSE ·

    **Revenue Growth:** Full-year (FY26) Net Sales grew by 512.7% to ₹3,224.86 Lakhs compared to the previous year. **Profitability Plunge:** Despite the sales boom, full-year Profit After Tax (PAT) fell by 91.5% to ₹21.17 Lakhs. The company posted a net loss of ₹70.99 Lakhs in Q4 FY…

  94. Allots 83.43 Lakh Shares, Raises ₹147 Crore

    Religare Enterprises Ltd · RELIGARE · BSE ·

    The company has allotted 83,43,263 equity shares at an issue price of ₹235 per share upon the conversion of warrants. This allotment has resulted in a fund infusion of ₹147.05 crore for the company. The allottees include VIC Enterprises, JM Financial Credit Solutions, Ashish Dhaw…

  95. Corrects FY26 Results, Confirms 67% Profit Growth

    EFC (I) Limited · EFCIL · NSE ·

    This is a revised filing to correct a clerical error in the 'Investments' figure from the original May 28 submission; the strong performance metrics are unaffected. **FY26 Consolidated PAT:** Grew **66.7%** YoY to ₹23,465.77 Lakhs. **FY26 Consolidated Revenue:** Increased by **57…

  96. Analyst & Investor Meeting Concluded

    Union Bank of India · UNIONBANK · NSE ·

    The bank has confirmed the conclusion of its Analyst/Institutional Investor meeting held on June 01, 2026. This filing is a procedural notification to the stock exchanges as required by SEBI regulations. No material information or summary of the discussions was disclosed in this…

  97. Reports Strong FY26 Turnaround & Strategic Updates

    Kshitij Polyline Limited · KSHITIJPOL · NSE ·

    • Achieved a significant financial turnaround, reporting a Profit After Tax (PAT) of ₹3.55 Crore in FY26, compared to a loss of ₹9.30 Crore in FY25. • Revenue from Operations grew by 46.3% year-over-year to ₹44.75 Crore. • Successfully completed all payment obligations for the ac…

  98. Strategic Overhaul: Divests Non-Core Biz, Guides for 52% Growth in FY27

    AXISCADES Technologies Limited · AXISCADES · NSE ·

    **Major Divestment:** Signed a definitive agreement to sell its heavy engineering, energy, and automotive practice to **Akkodis** for **$30.63 million** in cash. **Value Unlocking:** The sale is expected to generate a significant one-time gain of approximately **₹41 per share** f…

  99. Publishes Transcript for Q4 & FY26 Earnings Webinar

    AXISCADES Technologies Limited · AXISCADES · NSE ·

    The company has filed the official transcript of its earnings webinar for the quarter and financial year ended March 31, 2026 (Q4 & FY26). The original earnings webinar was conducted on May 30, 2026. This document was filed with the exchanges on June 04, 2026, as per regulatory r…

  100. Upcoming Analyst & Investor Meeting

    Metropolis Healthcare Limited · METROPOLIS · NSE ·

    • Metropolis Healthcare will hold a group meeting with analysts and institutional investors from the Macquarie Healthcare Tour. • The meeting is scheduled for June 08, 2026, starting at 03:30 p.m. (IST). • The company has stated that no Unpublished Price Sensitive Information (UP…